Sunday, September 14, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

D-Wave Quantum Executive Liquidates $2.5 Million in Stock Amid Rally

Felix Baarz by Felix Baarz
September 14, 2025
in AI & Quantum Computing, Insider Trading, Tech & Software
0
D-Wave Quantum Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Shares of quantum computing firm D-Wave Quantum Inc. continued their remarkable ascent, closing Friday’s session with a 7.7% gain at $17.79. Trading activity surged to nearly 59.5 million shares, significantly above average volumes. This impressive performance provided an opportunity for Chief Financial Officer John Markovich to execute a substantial sale of his equity holdings.

Major Insider Transaction Executed

Corporate filings reveal that between September 10th and 12th, Markovich disposed of 150,000 shares at prices ranging from $16.30 to $17.50 per share, generating approximately $2.5 million in proceeds. Concurrently, he exercised options to acquire an equivalent number of shares at just $0.92 per share—a common practice among executives managing their compensation packages.

Following these transactions, Markovich retains direct ownership of 1,599,511 shares alongside 812,837 unvested restricted stock units. The sales occurred as the stock traded near its 52-week peak of $20.56, achieved earlier this year.

The company’s equity has delivered extraordinary returns, appreciating more than 1,550% over the past twelve months—a performance that stands out even within the high-growth technology sector.

Strong Financial Position Supports Growth Ambitions

D-Wave’s financial health appears robust, with the company reporting approximately $819 million in liquid assets at the conclusion of Q2 2025. This represents a staggering 1,900% increase compared to the previous year’s position. This substantial war chest provides significant flexibility for advancing research initiatives, accelerating development projects, and pursuing strategic acquisitions.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

The company’s second-quarter financial results demonstrated strong commercial progress, with revenue climbing 42% year-over-year to reach $3.1 million. This figure exceeded analyst expectations of $2.59 million. While the loss per share of $0.08 was slightly wider than the projected $0.05 loss, the revenue growth indicates expanding market adoption of the company’s quantum computing solutions.

Strategic Appointments and Product Development

In early September, D-Wave strengthened its leadership team with the appointment of Stan Black as Chief Information Security Officer. The company simultaneously launched new developer tools designed to accelerate innovation in quantum artificial intelligence applications.

D-Wave’s Advantage2 quantum system represents cutting-edge technology, featuring over 4,400 qubits with 20-way connectivity. The commercial adoption of this technology continues to accelerate through the Leap cloud service, which has processed more than 20.6 million problems to date—marking a 134% increase in just six months.

Analyst Community Maintains Positive Outlook

Wall Street analysts remain broadly optimistic about D-Wave’s prospects, with price targets ranging from $20 to $30 per share. The majority of research firms maintain buy recommendations on the stock. Piper Sandler recently raised its price objective from $13 to $22, while Benchmark reaffirmed its positive rating.

The company’s growing roster of enterprise clients—including Ford, GE Vernova, and Nikon—suggests successful transition from pure research to commercial application. The next significant test for the company will come with the release of Q3 financial results in early November.

Ad

D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from September 14 delivers the answer:

The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 14.

D-Wave Quantum: Buy or sell? Read more here...

Tags: D-Wave Quantum
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Xeris Pharmaceuticals Stock
Analysis

Mixed Signals Create Intriguing Scenario for Xeris Biopharma Investors

September 14, 2025
Lifestance Health Stock
Analysis

Lifestance Health Shares Navigate Volatile Terrain Amid Operational Gains

September 14, 2025
Western Alliance Bancorporation Stock
Analysis

Western Alliance Bancorporation Announces Major Share Repurchase Initiative

September 14, 2025
Next Post
Eli Lilly Stock

Eli Lilly Faces Dual Setbacks: Major Legal Penalty and UK Investment Freeze

ASML Stock

Semiconductor Trade Tensions Intensify for Dutch Equipment Maker ASML

AMD Stock

AMD Navigates Record Performance Amid Geopolitical Headwinds

Recommended

Axsome Stock

Axsome Therapeutics Emerges as a High-Growth Contender in Neurological Drug Development

4 weeks ago
Valuation business Market Capitalization

Understanding the Difference between a Business and a Company

2 years ago
FLO stock news

Truist Securities Analyst Upgrades Howmet Aerospace Stock with Raised Price Target

2 years ago

Norwegian Cruise Line Reports Q4 2023 Results and FullYear Outlook

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Western Alliance Bancorporation Announces Major Share Repurchase Initiative

Ocular Therapeutix: A Biotech Contender Balancing Promise and Financial Reality

Albertsons Charts Independent Path After Kroger Merger Collapse

Alphabet Navigates Major Defense Contract and Regulatory Setbacks Simultaneously

LyondellBasell Secures Financial Flexibility Amid Strategic Restructuring

AMD Navigates Record Performance Amid Geopolitical Headwinds

Trending

Xeris Pharmaceuticals Stock
Analysis

Mixed Signals Create Intriguing Scenario for Xeris Biopharma Investors

by Dieter Jaworski
September 14, 2025
0

Investors in Xeris Biopharma Holdings, Inc. are currently weighing contradictory market signals that present a compelling investment...

Lifestance Health Stock

Lifestance Health Shares Navigate Volatile Terrain Amid Operational Gains

September 14, 2025
Gladstone Commercial Stock

Gladstone Commercial’s High-Yield Appeal Amid Market Skepticism

September 14, 2025
Western Alliance Bancorporation Stock

Western Alliance Bancorporation Announces Major Share Repurchase Initiative

September 14, 2025
Ocular Therapeutix Stock

Ocular Therapeutix: A Biotech Contender Balancing Promise and Financial Reality

September 14, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Mixed Signals Create Intriguing Scenario for Xeris Biopharma Investors September 14, 2025
  • Lifestance Health Shares Navigate Volatile Terrain Amid Operational Gains September 14, 2025
  • Gladstone Commercial’s High-Yield Appeal Amid Market Skepticism September 14, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com